Cibenzoline succinate (Cifenline succinate) is the succinate form of Cibenzoline ( HY-106577 ). Cibenzoline succinate is an inhibitor for ATP-sensitive potassium ( KATP ) channel by affecting the pore-forming Kir6.2 subunit with IC 50 of 22.2 µM. Cibenzoline succinate affects insulin secretion and exhibits antiarrhythmic and antidiabetic activities.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Potassium Channel
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.